You are invited to a festive evening of entertainment and fun! Great bands Exciting raffle prizes Door prizes Delicious food!! and more… Where: Tapas Bar and Grill When: Thursday, November 15th Time: 6:30 PM – 10:30 PM Tickets: $30.00 Buy Tickets Now! Thank you for being part of Music Power...
Events
Last year, the International Workshop on AKU was extremely successful, and now the 6th International Workshop on AKU has been announced! The workshop will take place on the 1st and 2nd November 2012, at the Health Spa Piešťany in Slovakia. This one and a half day meeting will include talks...
The orphan drug and rare disease industry is one of the hottest topics in modern day medicine. With blockbuster drugs coming off patent, there is a great need for pharmaceutical companies to diversify their portfolios by exploring niche markets. The increasing presence of high-profile manufacturers in the orphan drug industry...
On behalf of the Organizing Committee and the Presidents of the Spanish Association of Medicine in Pharmaceutical Industry (AMIFE) and of the International Federation of Pharmaceutical Physicians (IFAPP) we are pleased to inform you about the upcoming Xth Congress of AMIFE and 16th International Conference on Pharmaceutical Medicine – ICPM...
Biovista, one of the world leaders in drug repositioning, is hosting a lunch and panel discussion on “Drug Repositioning in Rare and Orphan Diseases”, October 18th in Washington DC. Interested parties are invited to register at their site (http://www.biovista.com/events.php?article_id=159). The discussion will involve thought leaders from associations such as CFIDS,...
The EUROPLAN 2012-2015 – Inception Workshop on National Planning for Rare Diseases gathers all participants with the following objectives: To share among the participants strengths and weaknesses in developing National Plans and Strategies (NP/NS) on Rare Diseases (RD) To identify opportunities for developing NP/NS on RD To identify targets and stakeholders...
The FDA Office of Orphan Products Development along with the European Medicines Agency (EMA) Orphan Medicines Section will hold an Orphan Product Designation and Grant Workshop on Friday, October 12, 2012, from 8:30 a.m. to 5:30 p.m. The workshop will be held on the FDA’s White Oak Campus in Building...
On behalf of the Executive Committee of the European Huntington´s Disease Network (EHDN), the European Huntington´s Disease Association (EHA), the local organizers and the members of the Programme and Organizing Committee it is our pleasure to cordially invite you to attend the 7th EHDN Plenary Meeting which will be held...
This conference aims to provide an exchange of ideas about genetics, genomics and systems biology in the context of vascular biology to increase our understanding of vascular disease. As such, this innovative workshop will be of interest to a broad spectrum of investigators that do not normally interact with one...
The Joining FORCEs Against Hereditary Cancer Conference is a forum on hereditary breast and ovarian cancer.We welcome anyone concerned about hereditary cancer: cancer survivors, high-risk individuals, those with a BRCA mutation or family history of cancer, and health care providers who treat high-risk patients. Conference website: http://www.facingourrisk.org/events/annual_conference/index.php
Today, biospecimen collections are used by multiple groups for various aims, from basic research through clinical trials. A well-managed biobank is a critical prerequisite for high-quality biological research. The proper collection, processing, storage, and tracking of biospecimens are vital components allowing researchers to better link molecular and clinical information. Thus,...
The Joining FORCEs Against Hereditary Cancer Conference is a forum on hereditary breast and ovarian cancer.We welcome anyone concerned about hereditary cancer: cancer survivors, high-risk individuals, those with a BRCA mutation or family history of cancer, and health care providers who treat high-risk patients. More information Agenda
The 62nd Annual Meeting of the American Society of Human Genetics will be held at the Moscone Center in San Francisco, California from Tuesday, November 6 through Saturday, November 10, 2012. Registration is required for admittance to all scientific sessions, exhibits, posters, and other meeting events (unless otherwise indicated). The...
The organising committee is pleased to invite you to the 10th Asia-Pacific Conference on Human Genetics 2012 (APCHG2012) with the theme “Genetic and Genomic Medicine: Working Together Towards Health For All”. The APCHG2012 will be held in Kuala Lumpur, Malaysia and is organised by the Asia-Pacific Society of Human Genetics...
Description The main objective of the meeting is to bring together clinical research experts in JNCL to focus, for the first time, on establishing common ground for outcomes and infrastructure in support of Phase III Clinical Trials. Towards this end, it is anticipated that at the end of the meeting...
National Tay-Sachs & Allied Diseases Association (NTSAD) is proud to host the 55th annual gala. Join us as we honor the organization’s anniversary of 55 years providing care for families and leading the fight to bring treatments to trial. We can all look ahead to what the next chapter holds...
National Tay-Sachs & Allied Diseases Association (NTSAD) is proud to host the 55th annual gala. Join us as we honor the organization’s anniversary of 55 years providing care for families and leading the fight to bring treatments to trial. We can all look ahead to what the next chapter holds...
Europe’s leading forum for rare disease research and orphan drug advancement The 3rd annual World Orphan Drug Congress provides the most comprehensive yet focused forum for the rare disease industry. With 3 dedicated tracks this year, whether your focus is on the successful clinical development of your orphan drug portfolio,...
The Meeting For All Stakeholders in the Rare Disease/Orphan Product Community The US Conference on Rare Diseases & Orphan Products – Shaping the Future Now – annual meeting where stakeholders – patients, patient organizations, researchers, drug and device companies, investors, thought leaders and government – meet to focus on rare...
The European Society for Immunodeficiencies (ESID) is a non-profit organization with multiple aims. The main objectives are to facilitate the exchange of ideas and information among doctors, nurses, biomedical investigators, patients and their families concerned with primary immunodeficiency diseases and also to promote research on causes, mechanisms and treatment of...